These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 11296702
1. [Mechanisms of effects of adenosine and dopamine on modification of synapses in striato-nigral and striato-pallidal neurons]. Sil'kis IG. Ross Fiziol Zh Im I M Sechenova; 2001 Feb; 87(2):155-69. PubMed ID: 11296702 [Abstract] [Full Text] [Related]
2. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. Le Moine C, Svenningsson P, Fredholm BB, Bloch B. J Neurosci; 1997 Oct 15; 17(20):8038-48. PubMed ID: 9315922 [Abstract] [Full Text] [Related]
3. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia. Mayfield RD, Jones BA, Miller HA, Simosky JK, Larson GA, Zahniser NR. Synapse; 1999 Sep 15; 33(4):274-81. PubMed ID: 10421708 [Abstract] [Full Text] [Related]
4. The cortico-basal ganglia-thalamocortical circuit with synaptic plasticity. II. Mechanism of synergistic modulation of thalamic activity via the direct and indirect pathways through the basal ganglia. Silkis I. Biosystems; 2001 Jan 15; 59(1):7-14. PubMed ID: 11226622 [Abstract] [Full Text] [Related]
5. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Florán B, Barajas C, Florán L, Erlij D, Aceves J. Neuroscience; 2002 Jan 15; 115(3):743-51. PubMed ID: 12435413 [Abstract] [Full Text] [Related]
6. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Fuxe K, Ferré S, Zoli M, Agnati LF. Brain Res Brain Res Rev; 1998 May 15; 26(2-3):258-73. PubMed ID: 9651540 [Abstract] [Full Text] [Related]
7. [A possible mechanism of dopamine-induced synergistic disinhibition of thalamic cells via "direct" and "indirect" pathways in basal ganglia]. Sil'kis IG. Zh Vyssh Nerv Deiat Im I P Pavlova; 2001 May 15; 51(3):294-303. PubMed ID: 11550635 [Abstract] [Full Text] [Related]
8. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Neuroscience; 1999 May 15; 88(4):1005-8. PubMed ID: 10336115 [Abstract] [Full Text] [Related]
9. Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells. Salim H, Ferré S, Dalal A, Peterfreund RA, Fuxe K, Vincent JD, Lledo PM. J Neurochem; 2000 Jan 15; 74(1):432-9. PubMed ID: 10617149 [Abstract] [Full Text] [Related]
10. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Carlson JH, Bergstrom DA, Walters JR. Brain Res; 1987 Jan 06; 400(2):205-18. PubMed ID: 2880637 [Abstract] [Full Text] [Related]
11. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons. Svenningsson P, Fourreau L, Bloch B, Fredholm BB, Gonon F, Le Moine C. Neuroscience; 1999 Mar 06; 89(3):827-37. PubMed ID: 10199616 [Abstract] [Full Text] [Related]
12. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ, Marshall JF. Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899 [Abstract] [Full Text] [Related]
13. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. Ruskin DN, Rawji SS, Walters JR. J Pharmacol Exp Ther; 1998 Jul 01; 286(1):272-81. PubMed ID: 9655869 [Abstract] [Full Text] [Related]
14. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. Schiffmann SN, Vanderhaeghen JJ. J Neurosci; 1993 Mar 01; 13(3):1080-7. PubMed ID: 7680065 [Abstract] [Full Text] [Related]
15. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Chen JF, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M, Beilstein MA, Hackett E, Fink JS, Low MJ, Ongini E, Schwarzschild MA. Proc Natl Acad Sci U S A; 2001 Feb 13; 98(4):1970-5. PubMed ID: 11172060 [Abstract] [Full Text] [Related]
16. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Glass M, Dragunow M, Faull RL. Neuroscience; 2000 Feb 13; 97(3):505-19. PubMed ID: 10828533 [Abstract] [Full Text] [Related]
17. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia. Kase H. Biosci Biotechnol Biochem; 2001 Jul 13; 65(7):1447-57. PubMed ID: 11515525 [Abstract] [Full Text] [Related]
18. Dopaminergic regulation of striatal efferent pathways. Surmeier DJ, Kitai ST. Curr Opin Neurobiol; 1994 Dec 13; 4(6):915-9. PubMed ID: 7888777 [Abstract] [Full Text] [Related]
19. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF. Physiol Behav; 2007 Sep 10; 92(1-2):210-7. PubMed ID: 17572452 [Abstract] [Full Text] [Related]
20. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Kudlacek O, Just H, Korkhov VM, Vartian N, Klinger M, Pankevych H, Yang Q, Nanoff C, Freissmuth M, Boehm S. Neuropsychopharmacology; 2003 Jul 10; 28(7):1317-27. PubMed ID: 12784121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]